249 related articles for article (PubMed ID: 20034646)
1. The non-pathogenic Australian lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit haemorrhagic disease virus.
Strive T; Wright J; Kovaliski J; Botti G; Capucci L
Virology; 2010 Mar; 398(1):125-34. PubMed ID: 20034646
[TBL] [Abstract][Full Text] [Related]
2. Serological assays to discriminate rabbit haemorrhagic disease virus from Australian non-pathogenic rabbit calicivirus.
Liu J; Kerr PJ; Wright JD; Strive T
Vet Microbiol; 2012 Jun; 157(3-4):345-54. PubMed ID: 22333288
[TBL] [Abstract][Full Text] [Related]
3. Distribution and prevalence of the Australian non-pathogenic rabbit calicivirus is correlated with rainfall and temperature.
Liu J; Fordham DA; Cooke BD; Cox T; Mutze G; Strive T
PLoS One; 2014; 9(12):e113976. PubMed ID: 25486092
[TBL] [Abstract][Full Text] [Related]
4. The non-pathogenic Australian rabbit calicivirus RCV-A1 provides temporal and partial cross protection to lethal Rabbit Haemorrhagic Disease Virus infection which is not dependent on antibody titres.
Strive T; Elsworth P; Liu J; Wright JD; Kovaliski J; Capucci L
Vet Res; 2013 Jul; 44(1):51. PubMed ID: 23834204
[TBL] [Abstract][Full Text] [Related]
5. Prior exposure to non-pathogenic calicivirus RCV-A1 reduces both infection rate and mortality from rabbit haemorrhagic disease in a population of wild rabbits in Australia.
Cooke BD; Duncan RP; McDonald I; Liu J; Capucci L; Mutze GJ; Strive T
Transbound Emerg Dis; 2018 Apr; 65(2):e470-e477. PubMed ID: 29250929
[TBL] [Abstract][Full Text] [Related]
6. DIFFERENT SEROLOGICAL PROFILES TO CO-OCCURRING PATHOGENIC AND NONPATHOGENIC CALICIVIRUSES IN WILD EUROPEAN RABBITS (ORYCTOLAGUS CUNICULUS) ACROSS AUSTRALIA.
Cox TE; Liu J; de Ven RV; Strive T
J Wildl Dis; 2017 Jul; 53(3):472-481. PubMed ID: 28231031
[TBL] [Abstract][Full Text] [Related]
7. Benign Rabbit Caliciviruses Exhibit Evolutionary Dynamics Similar to Those of Their Virulent Relatives.
Mahar JE; Nicholson L; Eden JS; Duchêne S; Kerr PJ; Duckworth J; Ward VK; Holmes EC; Strive T
J Virol; 2016 Oct; 90(20):9317-29. PubMed ID: 27512059
[TBL] [Abstract][Full Text] [Related]
8. Benign Rabbit Calicivirus in New Zealand.
Nicholson LJ; Mahar JE; Strive T; Zheng T; Holmes EC; Ward VK; Duckworth JA
Appl Environ Microbiol; 2017 Jun; 83(11):. PubMed ID: 28363968
[TBL] [Abstract][Full Text] [Related]
9. In situ hybridisation assay for localisation of rabbit calicivirus Australia-1 (RCV-A1) in European rabbit (Oryctolagus cuniculus) tissues.
Hoehn M; Kerr PJ; Strive T
J Virol Methods; 2013 Mar; 188(1-2):148-52. PubMed ID: 23261802
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of a non-pathogenic and non-protective infectious rabbit lagovirus related to RHDV.
Le Gall-Reculé G; Zwingelstein F; Fages MP; Bertagnoli S; Gelfi J; Aubineau J; Roobrouck A; Botti G; Lavazza A; Marchandeau S
Virology; 2011 Feb; 410(2):395-402. PubMed ID: 21195443
[TBL] [Abstract][Full Text] [Related]
11. A sensitive and specific blocking ELISA for the detection of rabbit calicivirus RCV-A1 antibodies.
Liu J; Kerr PJ; Strive T
Virol J; 2012 Sep; 9():182. PubMed ID: 22943557
[TBL] [Abstract][Full Text] [Related]
12. Identification and partial characterisation of a new Lagovirus in Australian wild rabbits.
Strive T; Wright JD; Robinson AJ
Virology; 2009 Feb; 384(1):97-105. PubMed ID: 19049842
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis in rabbit haemorrhagic disease.
Jung JY; Lee BJ; Tai JH; Park JH; Lee YS
J Comp Pathol; 2000; 123(2-3):135-40. PubMed ID: 11032666
[TBL] [Abstract][Full Text] [Related]
14. Rabbit haemorrhagic disease: applying Occam's razor to competing hypotheses.
Peacock D; Mutze G; Sinclair R; Kovaliski J; Cooke B
Mol Ecol; 2012 Mar; 21(5):1038-41. PubMed ID: 22292800
[TBL] [Abstract][Full Text] [Related]
15. Monitoring the spread of rabbit hemorrhagic disease virus as a new biological agent for control of wild European rabbits in Australia.
Kovaliski J
J Wildl Dis; 1998 Jul; 34(3):421-8. PubMed ID: 9706550
[TBL] [Abstract][Full Text] [Related]
16. Serological evidence for a non-protective RHDV-like virus.
Marchandeau S; Le Gall-Reculé G; Bertagnoli S; Aubineau J; Botti G; Lavazza A
Vet Res; 2005; 36(1):53-62. PubMed ID: 15610723
[TBL] [Abstract][Full Text] [Related]
17. Persistence of rabbit haemorrhagic disease virus genome in vaccinated rabbits after experimental infection.
Gall A; Schirrmeier H
J Vet Med B Infect Dis Vet Public Health; 2006 Oct; 53(8):358-62. PubMed ID: 17010038
[TBL] [Abstract][Full Text] [Related]
18. Benign circulation of rabbit haemorrhagic disease virus on Lambay Island, Eire.
Forrester NL; Trout RC; Gould EA
Virology; 2007 Feb; 358(1):18-22. PubMed ID: 17049958
[TBL] [Abstract][Full Text] [Related]
19. Rabbit haemorrhagic disease: are Australian rabbits (Oryctolagus cuniculus) evolving resistance to infection with Czech CAPM 351 RHDV?
Elsworth PG; Kovaliski J; Cooke BD
Epidemiol Infect; 2012 Nov; 140(11):1972-81. PubMed ID: 22244198
[TBL] [Abstract][Full Text] [Related]
20. A serological survey of antibodies to rabbit haemorrhagic disease virus (rabbit calicivirus disease) in two rural Central Otago communities.
Greenslade E; Weinstein P; Woodward A; Capucci L; Salmond C; Beasley R
N Z Med J; 2001 Feb; 114(1126):55-7. PubMed ID: 11280425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
